The artwork is fresh and current from a wide variety of artists and usually reflects their better pieces. The professional, juried shows and competitions held by organizations such as the OPA, American Impressionist Society, California Art Club, Portrait Society of America and others make it very easy for me to see the work of both established and emerging artists, since their members are already focused on high quality representational art. SJ: While I can’t speak for other gallery managers or owners, I can tell you a quite a bit about how I find artists and begin to follow them. Scott spoke on this topic at the Portrait Society of America’s annual conference in Atlanta last April.ĬS: Scott, would you talk about how an aspiring artist might be seen by in interested gallery?
“Scott is the epitome of a servant leader who embraces our mission – and who inspires others to aspire to our mission to save and enhance lives through the healing power of human cells and tissue,” said Rachel Beddard, MD, Senior Vice President and Chief Medical Officer at BioBridge Global.Scott Jones serves as the General Manager of Legacy Galleries (Scottsdale, AZ, Jackson, WY and Bozeman MT), among the foremost of representational fine art galleries in the country, shares with OPA members some of his insights into the gallery- artist relationship. He was an important contributor to the establishment of BioBridge Global’s cGMP cellular therapy testing services, which include development of potency assays and other applications to support advanced therapies. His expertise includes donor screening, cell and gene therapy testing and analytical development. “Scott serves as a key collaborator with BioBridge Global operating units in developing the organization’s donor-to-patient capabilities in the biotherapies arena, and as a valued consultant for customers,” Landon said. He also has provided support for clinical trials, especially those requiring FDA approval of assays and equipment. Jones’ work for the organization has included the development of multiple custom assays and products for applications in regenerative medicine. He is also an active member of AABB and SCABB. He has authored and delivered numerous oral and poster presentations at annual meetings for the South Central Association of Blood Banks (SCABB), the Association for the Advancement of Blood & Biotherapies (AABB) and the Congress of International Society of Blood Transfusion. He did post-doctorate work at the Texas Center for Infectious Disease, where he was the Director of the TB-RFLP Laboratory. Jones earned his bachelor’s degree in microbiology from Texas A&M University and a doctorate in microbiology from UT Health San Antonio. “That includes numerous custom assay scientific projects, building the R&D team, and serving as the key technical executive in the Community Labs initiative during the COVID-19 pandemic.” “This promotion recognizes Scott both for the many contributions he has made to building our R&D capabilities and for his strategic thought leadership,” Landon said. In his new role leading the organization’s growing research and development activities, Jones reports directly to CEO Martin Landon and supervises a team of nine, including seven scientists. Jones, who has been with the San Antonio-based nonprofit biomedical organization since 1999, previously was Vice President, Scientific Affairs.
Veteran scientist has led expansion of BioBridge Global’s research and development capabilitiesīioBridge Global announced today that Scott Jones, PhD has been promoted to Senior Vice President and Chief Scientific Officer.
0 kommentar(er)
